HIF-Prolyl Hydroxylase 2 Inhibition Enhances the Efficiency of Mesenchymal Stem Cell-Based Therapies for the Treatment of Critical Limb Ischemia
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2017 ◽
Vol 9
(2)
◽
pp. 239
◽
2014 ◽
Vol 86
(3)
◽
pp. 459-468
◽
Keyword(s):